InvestorsObserver
×
News Home

Is Aptorum Group Ltd (APM) a Good Choice in Biotechnology Monday?

Monday, February 22, 2021 02:02 PM | InvestorsObserver Analysts

Mentioned in this article

Is Aptorum Group Ltd (APM) a Good Choice in Biotechnology Monday?

Aptorum Group Ltd (APM) is near the bottom in its industry group according to InvestorsObserver. APM gets an overall rating of 10. That means it scores higher than 10 percent of stocks. Aptorum Group Ltd gets a 5 rank in the Biotechnology industry. Biotechnology is number 17 out of 148 industries.

Overall Score - 10
APM has an Overall Score of 10. Find out what this means to you and get the rest of the rankings on APM!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 10 means the stock is more attractive than 10 percent of stocks.

Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Aptorum Group Ltd Stock Today?

Aptorum Group Ltd (APM) stock has risen 11.31% while the S&P 500 has fallen -0.13% as of 1:55 PM on Monday, Feb 22. APM has gained $0.44 from the previous closing price of $3.89 on volume of 800,768 shares. Over the past year the S&P 500 has gained 20.95% while APM has fallen -69.16%. APM lost -$0.54 per share the over the last 12 months.

Click Here to get the full Stock Score Report on Aptorum Group Ltd (APM) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App